Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Future Med Chem. 2015 Jun;7(8):1023–1038. doi: 10.4155/fmc.15.44

Table 2.

Selected highly resistant protease mutants and Kd for Darunavir.

Protease Kd DRV (nM) Relative Kd Amino acid substitutions
Wild type 0.005 1.0
PR20 41.000 8200 Q7K, L10F, I13V, I15V, D30N, V32I, L33F, E35D, M36I, S37N, I47V, I54L, Q58E, I62V, L63P, A71V, I84V, N88D, L89T, L90M
P51 37.000 7400 L10I, I15V, K20R, L24I, V32I, I33F, M36I, M46L, I54M, I63P, K70Q, V82I, I84V, L89M
PRdrv1§ 15.000 3000 L10I, M36V, M46L, I54V, I62V, L63P, A71V, V82A, I84V, L90M
PRdrv2§ 0.750 150 T12V, I13V, I15V, K20M, V32I, L33F, K43T, I54L, K55N, I62V, L63P, A71V, I72V, G73S, V77I, V82L, I84V, L89V, L90M
PRdrv3§ 0.004 0.82 I13V, K20R, V32I, L33F, E35D, M36I, R41K, K43T, I47V, I54M, I62V, L63V, A71V, I72T, G73S, T74P, V82L, L89V, I93L
PRdrv4§ 35.000 7000 L10F, I13V, D30N, K45I, I50L, L63P, A71I, V77I, N88D
PRdrv5§ 0.370 74 L10I, I13V, K14R, V32I, L33F, K43T, M46I, I47V, I54L, I62V, L63P, A71T, I72T, G73T, V77I, P79S, I84V, L90M
PRdrv6§ 1.800 360 L10I, I13V, G16E, L33F, M36L, N37T, P39S, K45R, M46L, I54V, K55R, I62V, L63P, A71V, G73D, V82T, I84V, L89V, L90M, I93L

Comparison of drug resistant HIV protease variants bearing multiple substitutions and the DRV binding affinity measured by isothermal titration calorimetry. Assays used different conditions, and may not be directly comparable to each other. Major mutations from Table 1 are shown in bold and underlined.

Data taken from [42].

Selected in vitro. Other mutants are from clinical isolates.

§

Data taken from [41].